/T

Shuyun Ma1,2, Biaojie Huang3,4, Jiahui Wang1

  • 1Department of Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

iScience
|October 27, 2025
PubMed
概括

这项研究揭示了自然杀手/T细胞淋巴瘤 (NKTCL) 中明显的恶性细胞程序. 抑制脂肪酸结合蛋白5 (FABP5) 显示出治疗这种侵袭性癌症的前景.